The standout is the 87.5% one‑year return, far exceeding the S&P's 63.8%; this outsized gain underscores PEB’s ability to generate superior total returns through both price appreciation and robust dividend distributions in a volatile hospitality environment.
A key risk is the negative five‑year and ten‑year annualized returns (-5.5% and -1.9%), which reflect sensitivity to occupancy downturns and higher financing costs; a sustained rise in interest rates could compress net operating income, potentially turning modest gains into deeper losses.
The 84.9 RSI indicates the stock is deeply overbought; if smart money begins to unwind positions, the constrained float could trigger a rapid price decline, potentially erasing up to half of the recent 16.4% drawdown buffer.
The 53% YoY revenue jump is the most striking growth driver, underscoring that Pebblebrook's expansion strategy hinges on acquisitions; if the integration delivers incremental cash flow, it can substantially improve return metrics, but reliance on deal‑driven growth also adds execution risk.
The negative gross margin of -6.7% is a red flag; if occupancy and ADR fail to improve by at least 2‑3 percentage points, the trust could slip deeper into loss territory, constraining cash flow needed for debt service and shareholder distributions.
The collapse in net profit margin to -4.5% is the pivotal driver of the negative ROE, underscoring that operational profitability has eroded faster than any efficiency gains or leverage benefits could compensate.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -2.7 | -4.5 | 0.28 | 2.17 | 1.5 | -1.2 | |
| 2024 | -0.2 | -0.3 | 0.26 | 2.11 | 1.6 | -0.1 | |
| 2023 | -2.8 | -5.5 | 0.24 | 2.11 | 0.8 | -1.3 | |
| 2022 | -2.9 | -6.3 | 0.23 | 2.05 | 0.3 | -1.4 | |
| 2021 | -5.9 | -25.2 | 0.12 | 1.98 | -1.5 | -3.0 | |
| 2020 | -12.0 | -88.4 | 0.07 | 1.87 | -5.0 | -6.4 | |
| 2019 | 3.2 | 7.2 | 0.25 | 1.79 | 3.7 | 1.8 | |
| 2018 | 0.4 | 1.6 | 0.12 | 1.86 | 36.7 | 1.0 | 0.2 |
| 2017 | 6.7 | 13.0 | 0.30 | 1.73 | 5.0 | 3.9 | |
| 2016 | 4.6 | 9.0 | 0.29 | 1.75 | 5.3 | 2.6 | |
| 2015 | 5.4 | 12.3 | 0.25 | 1.74 | 4.4 | 3.1 |
The negative cash conversion cycle of -38 days quantifies a liquidity strain: the firm must fund operations and debt service with external financing, raising refinancing risk if cash flow does not rebound.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1323 | 0 | 8 | 46 | -38 | |
| 2024 | 1430 | 0 | 10 | 75 | -65 | |
| 2023 | 1497 | 0 | 11 | 82 | -70 | |
| 2022 | 1608 | 0 | 12 | 91 | -79 | |
| 2021 | 3118 | 0 | 18 | 150 | -132 | |
| 2020 | 5008 | 0 | 8 | 167 | -159 | |
| 2019 | 1471 | 0 | 11 | 86 | -75 | |
| 2018 | 3070 | 0 | 26 | 88 | 232 | -206 |
| 2017 | 1229 | 0 | 14 | 14 | 100 | -86 |
| 2016 | 1256 | 0 | 12 | 13 | 102 | -90 |
| 2015 | 1450 | 0 | 12 | 14 | 101 | -89 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $5348M | $2785M | $2469M | $2457M | $2273M | $184M | $230M | $328M |
| 2024 | $5693M | $2905M | $2697M | $2567M | $2361M | $207M | $257M | $355M |
| 2023 | $5825M | $2975M | $2764M | $2640M | $2457M | $184M | $238M | $1257M |
| 2022 | $6134M | $3049M | $2997M | $2708M | $2667M | $41M | $98M | $849M |
| 2021 | $6261M | $3097M | $3156M | $2761M | $2703M | $59M | $129M | $336M |
| 2020 | $6076M | $2812M | $3257M | $2791M | $2666M | $124M | $194M | $276M |
| 2019 | $6499M | $2867M | $3621M | $2742M | $2712M | $30M | $166M | $381M |
| 2018 | $6970M | $3208M | $3751M | $2747M | $2664M | $83M | $244M | $462M |
| 2017 | $2591M | $1087M | $1499M | $885M | $860M | $25M | $105M | $183M |
| 2016 | $2809M | $1200M | $1606M | $996M | $963M | $33M | $107M | $185M |
| 2015 | $3063M | $1302M | $1758M | $1110M | $1084M | $26M | $103M | $174M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $250M | $10M | $-281M | $-97M | $152M | $-79M | $-5M |
| 2024 | $275M | $-93M | $-158M | $275M | $-17M | $-5M | |
| 2023 | $236M | $142M | $-237M | $236M | $-93M | $-5M | |
| 2022 | $279M | $-109M | $-209M | $-117M | $162M | $-71M | $-5M |
| 2021 | $71M | $-82M | $-33M | $-84M | $-13M | $-1M | $-5M |
| 2020 | $-202M | $250M | $31M | $-125M | $-327M | $-1M | $-54M |
| 2019 | $395M | $300M | $-746M | $-1M | $394M | $-4M | $-185M |
| 2018 | $136M | $-1778M | $1718M | $-0M | $136M | $-3M | $-106M |
| 2017 | $195M | $131M | $-334M | $-0M | $195M | $-96M | $-107M |
| 2016 | $241M | $299M | $-533M | $-0M | $241M | $-228M | $-105M |
| 2015 | $221M | $-400M | $153M | $-0M | $220M | $-4M | $-84M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net